Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;5 Suppl 4(Suppl 4):S389-96.
doi: 10.3978/j.issn.2072-1439.2013.07.10.

Treatment of non-small cell lung cancer (NSCLC)

Konstantinos Zarogoulidis  1 , Paul Zarogoulidis, Kaid Darwiche, Efimia Boutsikou, Nikolaos Machairiotis, Kosmas Tsakiridis, Nikolaos Katsikogiannis, Ioanna Kougioumtzi, Ilias Karapantzos, Haidong Huang, Dionysios Spyratos
Affiliations
Review

Treatment of non-small cell lung cancer (NSCLC)

Konstantinos Zarogoulidis et al. J Thorac Dis. 2013 Sep.

Abstract

Radical surgery is the standard of care for fit stage I non-small cell lung cancer (NSCLC) patients. Adjuvant treatment should be offered only as part of an investigation trial. Stage II and IIIA adjuvant cisplatin-based chemotherapy remains the gold standard for completely resected NSCLC tumors. Additionally radiotherapy should be offered in patients with N2 lymph nodes. In advanced stage IIIB/IV or inoperable NSCLC pts, a multidisciplinary treatment should be offered consisted of 4 cycles of cisplatin-based chemotherapy plus a 3(rd) generation cytotoxic agent or a cytostatic (anti-EGFR, anti-VEGFR) drug.

Keywords: Non-small cell lung cancer (NSCLC); lung cancer; targeted treatment; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Treatment algorithm for NSCLC. (T, tumor; Ν, lymphnodes; Μ, metastasis).
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96 - PubMed
    1. Chansky K, Sculier JP, Crowley JJ, et al. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801 - PubMed
    1. Robinson LA, Ruckdeschel JC, Wagner H Jr, et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:243S-265S. - PubMed
    1. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-9 - PubMed
    1. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633-41 - PubMed